secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVITA Medical, Inc. (RCEL)
CIK:        0001762303
Form:       8-K
Filed at:   2026-06-03T23:19:36+00:00
Accession:  0001762303-26-000003
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

AVITA Medical shareholders approve director fee pool increase, equity grants, and warrant issuance
--------------------------------------------------------------------------------

- Non-executive director cash fee pool increased from $750K to $900K per annum.
- Annual equity grants of 22,214 RSUs and 16,133 options approved for each of six non-executive directors.
- Initial grants to Dr. Tarnoff: 26,250 RSUs + 19,063 options; to Joseph Woody: 40,547 RSUs + 29,446 options.
- Warrants for up to 650,000 shares (10-year term) to Perceptive Credit Holdings approved.
- Shareholders authorized additional 10% equity issuance capacity under ASX Listing Rule 7.1A.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1762303/000176230326000003/0001762303-26-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1762303/000176230326000003/rcel-20260603.htm
  HTML page:      https://secwatch.observer/filing/0001762303-26-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer